Reverter JC[au] - Search Results

Year	Number of Results
1983	1
1985	2
1986	1
1987	4
1988	8
1989	7
1990	6
1991	9
1992	8
1993	9
1994	5
1995	5
1996	9
1997	12
1998	5
1999	6
2000	8
2001	3
2002	11
2003	3
2004	5
2005	6
2006	4
2007	8
2008	5
2009	9
2010	5
2011	11
2012	6
2013	6
2014	2
2015	9
2016	9
2017	4
2018	10
2019	6
2020	6
2021	2

1

In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation.

Blasi A, von Meijenfeldt FA, Adelmeijer J, Calvo A, Ibañez C, Perdomo J, Reverter JC, Lisman T. Blasi A, et al. Among authors: reverter jc. J Thromb Haemost. 2020 Oct;18(10):2646-2653. doi: 10.1111/jth.15043. Epub 2020 Sep 1. J Thromb Haemost. 2020. PMID: 32762118 Free PMC article.

2

High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?

Ibañez C, Perdomo J, Calvo A, Ferrando C, Reverter JC, Tassies D, Blasi A. Ibañez C, et al. Among authors: reverter jc. J Thromb Thrombolysis. 2021 Feb;51(2):308-312. doi: 10.1007/s11239-020-02226-0. Epub 2020 Jul 15. J Thromb Thrombolysis. 2021. PMID: 32671609 Free PMC article. Clinical Trial.

3

Reply.

Blasi A, Hernandez-Gea V, Reverter JC, Garcia-Pagán JC. Blasi A, et al. Among authors: reverter jc. Hepatology. 2016 Jul;64(1):321-2. doi: 10.1002/hep.28371. Epub 2016 Jan 14. Hepatology. 2016. PMID: 26605874 No abstract available.

4

Coagulation Failure in Patients With Acute-on-Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio.

Blasi A, Calvo A, Prado V, Reverter E, Reverter JC, Hernández-Tejero M, Aziz F, Amoros A, Cardenas A, Fernández J. Blasi A, et al. Among authors: reverter jc. Hepatology. 2018 Dec;68(6):2325-2337. doi: 10.1002/hep.30103. Epub 2018 Nov 9. Hepatology. 2018. PMID: 29790188

5

[Platelet antiaggregants].

Reverter JC. Reverter JC. Med Clin (Barc). 2000 Jul 8;115(6):214-5. Med Clin (Barc). 2000. PMID: 11002460 Review. Spanish. No abstract available.

6

Fondaparinux sodium.

Reverter JC. Reverter JC. Drugs Today (Barc). 2002 Mar;38(3):185-94. doi: 10.1358/dot.2002.38.3.820126. Drugs Today (Barc). 2002. PMID: 12532174 Review.

7

Study of Biocompatibility of Membranes in Online Hemodiafiltration.

Ojeda R, Arias-Guillén M, Gómez M, Vera M, Fontseré N, Rodas L, Filella X, Reverter JC, Lozano F, Villamor N, Maduell F. Ojeda R, et al. Among authors: reverter jc. Blood Purif. 2020;49(4):400-408. doi: 10.1159/000504954. Epub 2019 Dec 19. Blood Purif. 2020. PMID: 31865336

8

Congenital antithrombin deficiency in patients with splanchnic vein thrombosis.

Baiges A, de la Morena-Barrio ME, Turon F, Miñano A, Alberto Ferrusquía J, Magaz M, Reverter JC, Vicente V, Hernández-Gea V, Corral J, García-Pagán JC. Baiges A, et al. Among authors: reverter jc. Liver Int. 2020 May;40(5):1168-1177. doi: 10.1111/liv.14342. Epub 2020 Jan 16. Liver Int. 2020. PMID: 31885188

9

Host-Derived Molecules as Novel Chagas Disease Biomarkers: Hypercoagulability Markers in Plasma.

Alonso-Padilla J, Tassies D, Cortes-Serra N, Gascon J, Reverter JC, Pinazo MJ. Alonso-Padilla J, et al. Among authors: reverter jc. Methods Mol Biol. 2019;1955:275-286. doi: 10.1007/978-1-4939-9148-8_21. Methods Mol Biol. 2019. PMID: 30868535

10

Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center.

Serrano R, Pons-Estel GJ, Espinosa G, Quintana RM, Reverter JC, Tassies D, Monteagudo J, Cervera R. Serrano R, et al. Among authors: reverter jc. Lupus. 2020 Aug;29(9):1050-1059. doi: 10.1177/0961203320933009. Epub 2020 Jun 14. Lupus. 2020. PMID: 32536318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results